Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Botanix Pharmaceuticals Limited ( (AU:BOT) ) has provided an announcement.
Botanix Pharmaceuticals Limited announced that Shenasaby Investments Pty Ltd, acting as a trustee for the Shenasaby Trust, has ceased to be a substantial holder in the company as of June 28, 2024. This change is attributed to a dilution of shareholding resulting from the placement of new shares, affecting over 74 million ordinary shares. This development may impact the company’s shareholder structure and influence voting interests, which could have implications for its governance and strategic decisions moving forward.
More about Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Limited is a company in the pharmaceuticals industry, focusing on the development and commercialization of dermatology and antimicrobial products. Their market focus includes addressing unmet medical needs through innovative treatments.
YTD Price Performance: 4.55%
Average Trading Volume: 5,100,206
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$827M
For an in-depth examination of BOT stock, go to TipRanks’ Stock Analysis page.